Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Plan B Delay Draws Criticism From Congress, Academia, FDA Official

Related Content

Crawford’s First Business After Confirmation: Brief Senators On Mifeprex

Jul 25 2005

Plan B “Not Approvable” Decision Puts FDA, CDER Director In Hot Seat

May 10 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window